MDRX News and Press, Allscripts Healthcare Solutions Inc. From 02/28/24

Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, today announced that Dr. Yin Ho, Veradigm interim Chief Executive Officer, and Lee Westerfield, interim Chief Financial Officer, will present at the TD Cowen Annual Health Care Conference ...

Continues to Work Diligently Towards Regaining Compliance Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, announced today that, as expected, it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indi...

Expects Not to File Required Financial Statements by Nasdaq’s February 27, 2024 Deadline Working Diligently to File Required Financial Statements and Restore Listing Adopts Limited Duration Stockholder Rights Plan Veradigm Inc. (NASDAQ: MDRX) (the “Comp...

Veradigm to Leverage ScienceIO’s Leading Healthcare Artificial Intelligence (AI) Platform on the Company’s Large-Scale, High-Quality Data Set to Build Advanced, Private Language Models for Healthcare Expected to Provide Highly Differentiated and More Advanced Products to Ver...

Using de-identified data for 53 million unique cardiovascular patients, the report examines prevalence across all 50 states and a variety of demographics Which region of the U.S. has the highest rates of hypertension, coronary artery disease and heart failure? The South, according to th...

Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the launch of TRANSFORM VAX, an American College of Cardiology (ACC)-sponsored initiative aimed at improving cardiovascular health through increased influenza vaccination education. ...

SAN DIEGO, CA / ACCESSWIRE / January 23, 2024 / The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Veradigm Inc. f.k.a. Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) shares. Investors, who purchased shares of Veradigm Inc. f.k.a. Allscripts Health...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in Veradigm securities between February 26, 2021 and December 7, 2023 a...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in Veradigm securities between February 26, 2021 and December 7, 2023 a...

Radnor, Pennsylvania--(Newsfile Corp. - January 16, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Veradigm ...